NeuroSense Therapeutics
(NASDAQ) NRSN
NeuroSense Therapeutics Financials at a Glance
Market Cap
$23.42M
Revenue (TTM)
$0.00
Net Income (TTM)
$8.66M
EPS (TTM)
$-0.58
P/E Ratio
-1.35
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.78
Volume
0
Open
$0.80
Price
$0.78
Volume
0
Open
$0.80
Previous Close
$0.78
Daily Range
$0.77 - $0.80
52-Week Range
$0.68 - $2.60
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.78
Volume
0
Open
$0.80
Previous Close
$0.78
Daily Range
$0.77 - $0.80
52-Week Range
$0.68 - $2.60
NRSN News
NRSN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NeuroSense Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
15
CEO
Alon Ben-Noon, MBA
Website
www.neurosense-tx.comHeadquarters
Herzliya, 4672562, IL
NRSN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-2880%
Return on Capital
17%
Return on Assets
-5%
Earnings Yield
-74.07%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$23.42M
Shares Outstanding
29.70M
Volume
0
Short Interest
0.00%
Avg. Volume
227.86K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$9.90M
EBITDA
$9.88M
Operating Cash Flow
$10.13M
Capital Expenditure
$3.00K
Free Cash Flow
$10.14M
Cash & ST Invst.
$3.38M
Total Debt
$73.00K
NeuroSense Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$23.42M
N/A
Market Cap/Employee
$1.38M
N/A
Employees
17
N/A
Net Income
$2.35M
-174.7%
EBITDA
$2.34M
+22.6%
Quarterly Fundamentals
Net Cash
$666.00K
-44.8%
Accounts Receivable
$847.00K
+125.3%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
N/A
Return on Assets
-5.14%
N/A
Return on Invested Capital
16.51%
N/A
Free Cash Flow
$2.00K
N/A
Operating Cash Flow
$2.00K
N/A